University of Kentucky researchers have discovered a possible added benefit of a novel new drug that lowers blood pressure.
Dr. Lisa Cassis and Dr. Alan Daugherty found in animal studies that aliskiren not only lowered blood pressure but also significantly reduced artery-clogging lesions that are the leading cause of heart attack and stroke, the top cause of death worldwide.
"In my many years of atherosclerosis research, this is one of the most striking effects I have seen on preventing the disease under experimental conditions," Daugherty said. "This contributes to our knowledge of the underlying disease that causes heart attack and stroke."
Cassis is director of the UK Graduate Center for Nutritional Sciences and Daugherty is director of the UK Cardiovascular Research Center. Their work will appear in the March issue of the
Journal of Clinical Investigation and is available online beginning today at
http://www.jci.org .
Aliskiren, marketed under the brand name Tekturna by pharmaceutical manufacturer Novartis, is the first new class of blood pressure medication approved by the FDA in more than a decade. Approved a year ago, it acts differently than any other medication currently on the market by inhibiting renin, an enzyme that is primarily produced in the kidneys. Renin is the first step in the synthesis of one of the most important molecules in blood pressure regulation.
"Our data shows that renin inhibition is an effective approach to both lowering blood pressure and directly inhibiting atherosclerosis. It will be interesting to determine whether this approach is more effective than the two other commonly used classes of drugs in the angiotensin system; ACE inhibitors and ARBs," Daugherty said.
Source: University of Kentucky
Related stories:
Atherosclerosis solution is likely many years away
While advances have been made in understanding how genetics, metabolism of HDL and LDL cholesterol, the inflammatory process, blood clots, and blood pressure regulation all play a part in the atherosclerosis disease process, a solution is likely many years away and will require huge -- but worthwhile -- investments of time, money and collaboration across fields of study.
Insomnia in women with breast cancer linked to heart rate dysregulation
A study in the October 15 issue of the
Journal of Clinical Sleep Medicine shows that respiratory sinus arrhythmia (RSA) is a significant predictor of insomnia in women with breast cancer and confirmed that longer nocturnal wake episodes were associated with a flatter diurnal cortisol slope.
Apple to offer $999 entry laptop, better graphics (Update 2)
(AP) -- Apple Inc. touched up its line of laptop computers Tuesday with a minimal nod to the economic turmoil that might push consumers to be more frugal this holiday shopping season.
Larger labs report kidney function routinely
Labs that conduct the highest number of routine blood tests are more likely than others to report estimated glomerular filtration rate (eGFR), an important measure of kidney function that can identify early kidney disease, according to a survey funded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the National Institutes of Health (NIH). The work is reported in the October issue of the
American Journal of Kidney Diseases.
Obese teenagers face higher metabolic syndrome risk in South America than Europe
Obese teenagers are much more likely to suffer from metabolic syndrome - which can lead to heart disease – if they live in Brazil than Italy, according to a study in the October issue of
IJCP, the
International Journal of Clinical Practice.
More Americans have, get treated for high blood pressure
First, the bad news: More American adults have hypertension (high blood pressure) and prehypertension than ever before.
Why sufferers from Alzheimer's disease might have lower blood pressure
A new study (
http://dx.doi.org/10.1016/j.bihy.2008.04.006) published in
Bioscience Hypotheses (
http://www.elsevier.com/locate/issn/1756-2392), a recently launched Elsevier journal, proposes that some people suffering from Alzheimer's disease experience a reduction in their high blood pressure because of cognitive decline.
Primary care records improve public health information
Gaining a fuller and more accurate picture of trends in the most important disease risk factors is now possible, thanks to a project between the NHS Information Centre and QResearch®.